title: Drugs for smoking cessation.
authors.affiliation: Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford OX2 6GG, UK Jamie.hartmann-boyce@phc.ox.ac.uk.
authors.forename: Jamie
authors.initials: J
authors.lastname: Hartmann-Boyce
authors.affiliation: Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford OX2 6GG, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Aveyard
mesh_terms: D016642:Bupropion / Q000627:therapeutic use; D000075202:Contraindications; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000188:drug therapy*; D000068580:Varenicline / Q000627:therapeutic use
chemical_list: D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D016642:Bupropion; D000068580:Varenicline